Next Article in Journal
A Randomized, Crossover, Single-Dose Bioequivalence Study of Two Extended-Release Tablets of Donepezil 23 mg in Healthy Human Volunteers under Fasting and Fed States
Previous Article in Journal
Nitric Oxide is a Potential Diagnostic Marker for Hepatocellular Carcinoma
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Iontophoresis: A Potential Emergence of a Transdermal Drug Delivery System

by
Vinod DHOTE
1,
Punit BHATNAGAR
1,
Pradyumna K. MISHRA
2,
Suresh C. MAHAJAN
1 and
Dinesh K. MISHRA
1,*
1
Mahakal Institute of Pharmaceutical Studies, Ujjain, M. P., India
2
Division of Translational Research, ACTREC, Tata Memorial Centre, Navi Mumbai, India
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2012, 80(1), 1-28; https://doi.org/10.3797/scipharm.1108-20
Submission received: 25 August 2011 / Accepted: 13 December 2011 / Published: 13 December 2011

Abstract

The delivery of drugs into systemic circulation via skin has generated much attention during the last decade. Transdermal therapeutic systems propound controlled release of active ingredients through the skin and into the systemic circulation in a predictive manner. Drugs administered through these systems escape first-pass metabolism and maintain a steady state scenario similar to a continuous intravenous infusion for up to several days. However, the excellent impervious nature of the skin offers the greatest challenge for successful delivery of drug molecules by utilizing the concepts of iontophoresis. The present review deals with the principles and the recent innovations in the field of iontophoretic drug delivery system together with factors affecting the system. This delivery system utilizes electric current as a driving force for permeation of ionic and non-ionic medications. The rationale behind using this technique is to reversibly alter the barrier properties of skin, which could possibly improve the penetration of drugs such as proteins, peptides and other macromolecules to increase the systemic delivery of high molecular weight compounds with controlled input kinetics and minimum inter-subject variability. Although iontophoresis seems to be an ideal candidate to overcome the limitations associated with the delivery of ionic drugs, further extrapolation of this technique is imperative for translational utility and mass human application.
Keywords: Drug delivery; Translational research; Transdermal therapeutic system; Iontophoresis Drug delivery; Translational research; Transdermal therapeutic system; Iontophoresis

Share and Cite

MDPI and ACS Style

DHOTE, V.; BHATNAGAR, P.; MISHRA, P.K.; MAHAJAN, S.C.; MISHRA, D.K. Iontophoresis: A Potential Emergence of a Transdermal Drug Delivery System. Sci. Pharm. 2012, 80, 1-28. https://doi.org/10.3797/scipharm.1108-20

AMA Style

DHOTE V, BHATNAGAR P, MISHRA PK, MAHAJAN SC, MISHRA DK. Iontophoresis: A Potential Emergence of a Transdermal Drug Delivery System. Scientia Pharmaceutica. 2012; 80(1):1-28. https://doi.org/10.3797/scipharm.1108-20

Chicago/Turabian Style

DHOTE, Vinod, Punit BHATNAGAR, Pradyumna K. MISHRA, Suresh C. MAHAJAN, and Dinesh K. MISHRA. 2012. "Iontophoresis: A Potential Emergence of a Transdermal Drug Delivery System" Scientia Pharmaceutica 80, no. 1: 1-28. https://doi.org/10.3797/scipharm.1108-20

Article Metrics

Back to TopTop